跳转至内容
Merck
CN

D4065

地红霉素

analytical standard, for drug analysis

别名:

[9S(R)]-9-脱氧-11-脱氧-9,11-[亚氨[2-(2-甲氧基乙氧基)亚乙基]氧]红霉素；LY-237216

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C42H78N2O14
化学文摘社编号:
62013-04-1
分子量:
835.07
UNSPSC Code:
41116107
PubChem Substance ID:
329798792
MDL number:
MFCD00865041

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41+,42-/m1/s1

SMILES string

CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C4N[C@@H](COCCOC)OC([C@H]4C)[C@]1(C)O

InChI key

WLOHNSSYAXHWNR-KZYCBHIHSA-N

assay

≥95% (TLC)

form

solid

mol wt

apparent mol wt 835.1

technique(s)

HPLC: suitable, gas chromatography (GC): suitable

application(s)

forensics and toxicology
pharmaceutical (small molecule)
veterinary

format

neat

Quality Level

100

正在寻找类似产品? 访问 产品对比指南

General description

Chemical structure: macrolide

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H317

pcodes

P280

Hazard Classifications

Skin Sens. 1

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCG0791
MKCD2497
MKBV6004V
MKBV2310V
MKBQ6449V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Macrolides in dermatology.
Noah S Scheinfeld et al.
Clinics in dermatology, 21(1), 40-49 (2003-03-01)
From the Centers for Disease Control and Prevention. Sudden death in a traveler following halofantrine administration--Togo, 2000.
JAMA, 285(14), 1836-1836 (2001-04-28)
M M Wasilewski et al.
The Journal of antimicrobial chemotherapy, 46(2), 255-262 (2000-08-10)
We investigated the comparative efficacy and safety of dirithromycin and erythromycin in the treatment of skin and soft tissue infections in this double-blind, randomized, multicentre study, in which 439 patients were randomized to treatment with dirithromycin (500 mg daily for
Dilek Duran et al.
Journal of molecular modeling, 10(2), 94-101 (2004-01-15)
Dirithromycin is a macrolide antibiotic derived from erythromycin A. Dirithromycin is synthesized by the condensation of 9(S)-erythromycylamine with 2-(2-methoxyethoxy)-acetaldehyde. To gain insight into the synthesis, the condensation mechanism has been analyzed computationally by the AM1 method in the gas phase.
Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analyisis and studies on acellular and cell culture models. .
Montenez, J. P., et al.
Toxicology and Applied Pharmacology, 15, 129-129 (1999)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持